Medicxi Ventures Management »

Rapt Therapeutics shares owned by Medicxi Ventures Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Medicxi Ventures Management from 13F filings

Historical chart of Medicxi Ventures Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Medicxi Ventures Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Medicxi Ventures Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $22M 2.8M 8.00

More positions owned by Medicxi Ventures Management

Centessa Pharmaceuticals Sponsored Ads (CNTA)
Phathom Pharmaceuticals (PHAT)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Rapt Therapeutics
Aura Biosciences (AURA)

View all positions for Medicxi Ventures Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics